A recent strategic divestment by European Lithium has cast a glaring spotlight on what appears to be a profound market mispricing. The transaction underscores a staggering gap between the company’s market valuation and the implied worth of its remaining stake in Critical Metals Corp (CRML), raising questions about nearly a billion dollars in potentially overlooked assets.
Operational Milestone and Financial Reserves
Beyond its financial positioning, European Lithium has achieved a significant operational milestone. On February 2, 2026, the Austrian government formally extended the mining license for the flagship Wolfsberg lithium project. This renewal within the European Union solidifies the project’s regulatory standing and secures the development pathway for the Carinthia-based mine. Wolfsberg is the core asset for Critical Metals Corp, central to its ambition of supplying the European electric vehicle supply chain.
Financially, the company is now on solid footing. The proceeds from its recent share sale, combined with existing reserves, have bolstered its cash position to over 350 million AUD. This substantial liquidity provides a buffer to fund future exploration initiatives or offer support to Critical Metals if required, all without immediate dilution risk for its shareholders.
Decoding the Divestment and Its Implications
The catalyst for this valuation discussion was European Lithium’s partial sale of 2.5 million shares in its subsidiary, Critical Metals Corp. The move generated approximately 45 million Australian dollars in proceeds. However, the more critical figure lies in what the company retained: a continuing holding of over 45.5 million CRML shares.
Should investors sell immediately? Or is it worth buying European Lithium?
Based on the closing share price from February 4, 2026, this remaining stake alone carries a market value of roughly 689 million US dollars, equivalent to about 984 million AUD. The remarkable aspect of this calculation is that this single asset’s value dramatically exceeds the entire market capitalization of European Lithium on the Australian exchange, which stood at only around 360 million AUD at the time of the transaction.
Management’s Strategic Assurance
In response to the transaction, Chairman Tony Sage moved to clarify the strategy. He emphasized that the sale strengthens the company’s balance sheet without compromising its strategic foothold. To alleviate any market concerns about a potential oversupply of CRML shares and to signal confidence, the management team has committed to a lock-up period. They have pledged not to dispose of any further shares in the subsidiary for the next four months.
This situation presents investors with a pronounced “sum-of-the-parts” discrepancy. The market continues to trade European Lithium’s equity at a level far beneath the implied value of its NASDAQ-listed holding, even as its treasury is now well-funded for future ventures.
Ad
European Lithium Stock: Buy or Sell?! New European Lithium Analysis from February 8 delivers the answer:
The latest European Lithium figures speak for themselves: Urgent action needed for European Lithium investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.
European Lithium: Buy or sell? Read more here...
